|
AU2011239262A1
|
|
Osteoarthritis biomarkers and uses thereof
|
|
US2011223594A1
|
|
Methods, kits and compositions for determining severity and survival of heart failure in a subject
|
|
CN101370946A
|
|
Method and apparatus for correlating levels of biomarker products with disease
|
|
CN101627128A
|
|
Bladder cancer biomarkers and uses thereof
|
|
TW200716764A
|
|
Bladder cancer biomarkers and uses thereof
|
|
EP1846577A2
|
|
Method of diagnosing osteoarthritis employing the biomarkers IL13RA1 and CPT1A
|
|
US2005208519A1
|
|
Biomarkers for diagnosing schizophrenia and bipolar disorder
|
|
AU2004286343A1
|
|
Liver cancer biomarkers
|
|
CA2534661A1
|
|
Osteoarthritis biomarkers and uses thereof
|
|
US2004241729A1
|
|
Method for the detection of Chagas disease related gene transcripts in blood
|
|
CA2832266A1
|
|
Method of profiling gene expression in a human subject having diabetes
|
|
CA2702148A1
|
|
Method of profiling gene expression in a human subject having an infectious disease
|
